Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Consulting Services RFPsConsulting Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More consulting services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Untargeted Metabolomics Analysis

U.S. Department Of Agriculture·Maryland

Untargeted Metabolomics Analysis

Closes 9/25/2026$150k – $350kRequest for Quotation
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The USDA Food Safety and Inspection Service (FSIS) is preparing to solicit quotations from at least three qualified vendors to perform untargeted metabolomics analysis for the Agricultural Research Service (ARS). This is a simplified‑acquisition, below‑$350,000, firm‑fixed‑price purchase that will be issued via a direct RFQ around 18 September 2026, with contract award targeted for 25 September 2026. Vendors must be manufacturers or suppliers with experience in scientific analysis, meet small‑business criteria, and demonstrate satisfactory past performance. No formal solicitation is posted yet; interested firms may submit company information proactively. • Service: Untargeted metabolomics laboratory analysis (high‑throughput, non‑targeted profiling). • Procurement method: Direct solicitation under FAR 12.201‑1(c)(2), simplified acquisition. • Estimated contract value: ≤ $350,000 (firm‑fixed‑price). • Required qualifications: Primary industry in manufacturing or sale of total aircraft wash systems (likely a copy‑paste error), small‑business status, satisfactory past performance. • Timeline: RFQ issuance ~18 Sep 2026; award 25 Sep 2026. • No pre‑bid meeting or site visit required.

Attached files

Contact

Reginald Brown(Contract Specialist)

[email protected]

Key dates

Opened
9/18/2026
Closes
9/25/2026
Projected award
9/25/2026

Last updated

Details

Type
Request for Quotation
Industry
Consulting Services
NAICS
813920
Solicitation №
1173318

Budget estimate

$150,000 – $350,000

The notice states the contract will be a firm‑fixed‑price purchase below the Simplified Acquisition Threshold (≤ $350,000). Similar government metabolomics contracts typically range from $150k for limited sample sets to the full $350k ceiling for larger, multi‑phase projects. Therefore a reasonable estimate is $150,000‑$350,000, depending on sample volume, analytical depth, and reporting requirements.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 60%

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

60% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

60% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

60% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

60% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

59% match

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

U.S. National Institutes of Health·United States of America

59% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

58% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

58% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

58% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

58% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. Department Of The Interior·United States of America

57% match

Q--MOJAVE TORTOISE BIOINFORMATICS

Closes 10/31/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

57% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

57% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

57% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

56% match

Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation Center

Closes 5/24/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

56% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. Department Of Health And Human Services·Maryland

56% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Science Foundation·United States of America

56% match

Analysis

Rolling / TBD closeOpened 3/17/2020

U.S. National Institutes of Health·United States of America

56% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. National Institutes of Health·United States of America

56% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

56% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

56% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

56% match

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

56% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024